Literature DB >> 23525186

Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Mario García-Carrasco1, Claudia Mendoza-Pinto, César Jiménez-Hernández, Mario Jiménez-Hernández, Arnulfo Nava-Zavala, Carlos Riebeling.   

Abstract

Sjögren's syndrome (SS) is a chronic inflammatory systemic autoimmune disease. The disease spectrum extends from sicca syndrome to systemic involvement and extraglandular manifestations, and SS may be associated with malignancies, especially non-Hodgkin's lymphoma. Patients with SS present a broad spectrum of serologic features. Certain serological findings are highly correlated with specific clinical features, and can be used as prognostic markers.

Entities:  

Keywords:  Sjögren’s syndrome; clinical features; hematologic abnormalities; lymphoma; prognosis; serologic findings

Year:  2012        PMID： 23525186      PMCID： PMC3602968          DOI： 10.2217/ijr.12.64

Source DB:  PubMed          Journal:  Int J Clin Rheumtol        ISSN： 1758-4280


  56 in total

Review 1.  Pathophysiology of Sjögren's syndrome.

Authors:  Mario García-Carrasco; Salvador Fuentes-Alexandro; Ricardo O Escárcega; Gonzalo Salgado; Carlos Riebeling; Ricard Cervera
Journal:  Arch Med Res       Date:  2006-11       Impact factor: 2.235

Review 2.  Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations.

Authors:  Domenico Sansonno; Franco Dammacco
Journal:  Lancet Infect Dis       Date:  2005-04       Impact factor: 25.071

3.  Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.

Authors:  S R Pillemer; E L Matteson; L T Jacobsson; P B Martens; L J Melton; W M O'Fallon; P C Fox
Journal:  Mayo Clin Proc       Date:  2001-06       Impact factor: 7.616

4.  The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome.

Authors:  Gabriel J Tobón; Yves Renaudineau; Sophie Hillion; Divi Cornec; Valérie Devauchelle-Pensec; Pierre Youinou; Jacques-Olivier Pers
Journal:  Arthritis Rheum       Date:  2010-11

Review 5.  [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].

Authors:  Olivier Meyer
Journal:  Ann Med Interne (Paris)       Date:  2002-12

Review 6.  The geoepidemiology of Sjögren's syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Autoimmun Rev       Date:  2009-11-10       Impact factor: 9.754

7.  Anti-centromere antibody-seropositive Sjögren's syndrome differs from conventional subgroup in clinical and pathological study.

Authors:  Hideki Nakamura; Atsushi Kawakami; Tomayoshi Hayashi; Naoki Iwamoto; Akitomo Okada; Mami Tamai; Satoshi Yamasaki; Hiroaki Ida; Katsumi Eguchi
Journal:  BMC Musculoskelet Disord       Date:  2010-07-01       Impact factor: 2.362

8.  Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis.

Authors:  R I Fox; M Luppi; P Pisa; H I Kang
Journal:  J Rheumatol Suppl       Date:  1992-01

9.  Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.

Authors:  Evangelia Baimpa; Issa J Dahabreh; Michael Voulgarelis; Haralampos M Moutsopoulos
Journal:  Medicine (Baltimore)       Date:  2009-09       Impact factor: 1.889

10.  T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.

Authors:  Xiaomei Li; Xiangpei Li; Long Qian; Guosheng Wang; Hong Zhang; Xiaoqiu Wang; Ke Chen; Zhimin Zhai; Qing Li; Yiping Wang; David C H Harris
Journal:  J Rheumatol       Date:  2007-11-15       Impact factor: 4.666
View more
  12 in total

1.  Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.

Authors:  E J Ter Borg; J C Kelder
Journal:  Rheumatol Int       Date:  2017-04-19       Impact factor: 2.631

2.  Serum immunoglobulin G4 in Sjögren's syndrome: a pilot study.

Authors:  Maria Maślińska; Bożena Wojciechowska; Małgorzata Mańczak; Brygida Kwiatkowska
Journal:  Rheumatol Int       Date:  2020-02-15       Impact factor: 2.631

3.  CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.

Authors:  Santosh Kumar Mandal; Pulukool Sandhya; Jayakanthan Kabeerdoss; Janardana Ramya; Gowri Mahasampath; Debashish Danda
Journal:  Rheumatol Int       Date:  2018-03-14       Impact factor: 2.631

4.  Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Authors:  Jorge I Ramírez Sepúlveda; Marika Kvarnström; Per Eriksson; Thomas Mandl; Katrine Brække Norheim; Svein Joar Johnsen; Daniel Hammenfors; Malin V Jonsson; Kathrine Skarstein; Johan G Brun; Lars Rönnblom; Helena Forsblad-d'Elia; Sara Magnusson Bucher; Eva Baecklund; Elke Theander; Roald Omdal; Roland Jonsson; Gunnel Nordmark; Marie Wahren-Herlenius
Journal:  Biol Sex Differ       Date:  2017-08-08       Impact factor: 5.027

5.  Difference in clinical presentation between women and men in incident primary Sjögren's syndrome.

Authors:  Jorge I Ramírez Sepúlveda; Marika Kvarnström; Susanna Brauner; Chiara Baldini; Marie Wahren-Herlenius
Journal:  Biol Sex Differ       Date:  2017-05-12       Impact factor: 5.027

6.  Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.

Authors:  Rosalind Ramsey-Goldman; Roberta Vezza Alexander; Elena M Massarotti; Daniel J Wallace; Sonali Narain; Cristina Arriens; Christopher E Collins; Amit Saxena; Chaim Putterman; Kenneth C Kalunian; Tyler O'Malley; Thierry Dervieux; Arthur Weinstein
Journal:  Arthritis Rheumatol       Date:  2019-11-25       Impact factor: 10.995

7.  IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.

Authors:  Maria Maślińska; Małgorzata Mańczak; Brygida Kwiatkowska; Vince Ramsperger; Long Shen; Lakshmanan Suresh
Journal:  Rheumatol Int       Date:  2021-01-26       Impact factor: 2.631

Review 8.  Pathogenetic Mechanisms Implicated in Sjögren's Syndrome Lymphomagenesis: A Review of the Literature.

Authors:  Ioanna E Stergiou; Aikaterini Poulaki; Michael Voulgarelis
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

9.  Identification of a unique anti-Ro60 subset with restricted serological and molecular profiles.

Authors:  A Y S Lee; D Beroukas; L Brown; C Lucchesi; A Kaur; L Gyedu; N Hughes; Y H Ng; O Saran; T P Gordon; J J Wang
Journal:  Clin Exp Immunol       Date:  2020-09-17       Impact factor: 4.330

10.  Subgroups of Sjögren's syndrome patients categorised by serological profiles: clinical and immunological characteristics.

Authors:  Ewa Kontny; Aleksandra Lewandowska-Poluch; Magdalena Chmielińska; Marzena Olesińska
Journal:  Reumatologia       Date:  2018-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.